Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct
Capitol HillConversation with The Cancer Letter

Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct

July 15, 2022
Vol.48 No.28
By Matthew Bin Han Ong
Top 25 stories of 2021
EditorialFree

Top 25 stories of 2021

January 14, 2022
Vol.48 No.02
By Matthew Bin Han Ong
The Cancer Letter’s roadmap for reporting harassment
Free

The Cancer Letter’s roadmap for reporting harassment
Panel of experts responds to questions from women in oncology

December 31, 2021
Vol.48 No.01
By Alice Tracey
NIH ignored my report of sexual misconduct by Axel Grothey—and danced around questions from Congress
Guest Editorial

NIH ignored my report of sexual misconduct by Axel Grothey—and danced around questions from Congress

October 01, 2021
Vol.47 No.36
NIH tells Congress it lacked authority to investigate whistleblower complaints about Axel Grothey’s sexual misconduct
Capitol HillFree

NIH tells Congress it lacked authority to investigate whistleblower complaints about Axel Grothey’s sexual misconduct

September 24, 2021
Vol.47 No.35
By Matthew Bin Han Ong
In Grothey case, NIH gets failing grades on follow-up, transparency, internal compliance
Conversation with The Cancer LetterFree

In Grothey case, NIH gets failing grades on follow-up, transparency, internal compliance
Miller, Holman discuss NIH’s response to congressional inquiry on sexual misconduct

September 24, 2021
Vol.47 No.35
By Matthew Bin Han Ong
Physician peer group tackles workplace conflict resolution
FreeGuest Editorial

Physician peer group tackles workplace conflict resolution
Physician Just Equity provides support for physicians who experience workplace harassment, discrimination, retaliation

September 17, 2021
Vol.47 No.34
By Holly G. Atkinson, Nicole Segalini, Ursula Barghouth, Arianna L. Gianakos, Deborah Verran and Pringl Miller
Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors
Capitol HillFree

Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors

September 03, 2021
Vol.47 No.32
By Paul Goldberg and Matthew Bin Han Ong
Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law
Capitol HillFree

Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law

July 23, 2021
Vol.47 No.29
By Matthew Bin Han Ong
Let’s stop passing the buck on sexual harassment in academic medicine
FreeGuest Editorial

Let’s stop passing the buck on sexual harassment in academic medicine

June 25, 2021
Vol.47 No.25
By Shikha Jain, Arghavan Salles and Vineet Arora

Posts navigation

Previous123Next

Trending Stories

  • DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
  • “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
    In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account